Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2014 Jun 23;3(3):e000961. doi: 10.1161/JAHA.114.000961

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2014 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley Blackwell.

This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.

PMC Copyright notice

Figure 2. — AID‐TAT peptide improves developed pressure in hearts ex vivo. A through D, Left ventricular developed pressure (LVDevP) traces over time (compressed) of ex vivo hearts treated with 1 (A) or 10 μmol/L (B) of scrambled (AID(S)‐TAT) peptide or 1 (C) or 10 μmol/L (D) of active (AID‐TAT) peptide before ischemia‐reperfusion (Pre I/R) and after (Post I/R) as indicated. E, Mean±SEM of LVDevP for all hearts treated with 1 or 10 μmol/L of AID(S)‐TAT or AID‐TAT peptide as indicated (n represents number of hearts). Statistical significance was determined using the Kruskal‐Wallis test followed by Dunn's multiple comparison test. AID indicates alpha‐interacting domain; TAT, transactivator of transcription.